vs
MSC INDUSTRIAL DIRECT CO INC（MSM）与Insulet Corporation（PODD）财务数据对比。点击上方公司名可切换其他公司
MSC INDUSTRIAL DIRECT CO INC的季度营收约是Insulet Corporation的1.2倍（$965.7M vs $783.7M），Insulet Corporation净利率更高（13.0% vs 5.4%，领先7.6%），Insulet Corporation同比增速更快（31.2% vs 4.0%），Insulet Corporation自由现金流更多（$48.2M vs $7.4M），过去两年Insulet Corporation的营收复合增速更高（33.2% vs -3.4%）
MSC工业直销公司（MSC）通过旗下主要子公司MSC工业供应公司，是美国规模最大的工业设备分销商之一，可提供超过150万种金属加工及其他工业类产品，广泛服务于工业制造、维修运维等领域的客户需求。
Insulet Corporation是深耕糖尿病治疗领域的医疗器械企业，核心产品为胰岛素泵，通过持续皮下输注胰岛素的疗法为患者给药。其产品通常由泵主体、一次性胰岛素储药仓，以及包含皮下植入套管和连接管路的一次性输注套件构成，满足不同患者的治疗需求。
MSM vs PODD — 直观对比
营收规模更大
MSM
是对方的1.2倍
$783.7M
营收增速更快
PODD
高出27.2%
4.0%
净利率更高
PODD
高出7.6%
5.4%
自由现金流更多
PODD
多$40.8M
$7.4M
两年增速更快
PODD
近两年复合增速
-3.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $965.7M | $783.7M |
| 净利润 | $51.8M | $101.6M |
| 毛利率 | 40.7% | 72.6% |
| 营业利润率 | 7.9% | 18.7% |
| 净利率 | 5.4% | 13.0% |
| 营收同比 | 4.0% | 31.2% |
| 净利润同比 | 11.1% | 0.9% |
| 每股收益（稀释后） | $0.93 | $1.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSMPODD
| Q4 25 | $965.7M | $783.7M | ||
| Q3 25 | $978.2M | $706.3M | ||
| Q2 25 | $971.1M | $649.1M | ||
| Q1 25 | — | $569.0M | ||
| Q4 24 | $928.5M | $597.5M | ||
| Q3 24 | — | $543.9M | ||
| Q2 24 | $979.4M | $488.5M | ||
| Q1 24 | $935.3M | $441.7M |
净利润MSMPODD
| Q4 25 | $51.8M | $101.6M | ||
| Q3 25 | $56.5M | $87.6M | ||
| Q2 25 | $56.8M | $22.5M | ||
| Q1 25 | — | $35.4M | ||
| Q4 24 | $46.6M | $100.7M | ||
| Q3 24 | — | $77.5M | ||
| Q2 24 | $71.7M | $188.6M | ||
| Q1 24 | $61.8M | $51.5M |
毛利率MSMPODD
| Q4 25 | 40.7% | 72.6% | ||
| Q3 25 | 40.4% | 72.2% | ||
| Q2 25 | 41.0% | 69.7% | ||
| Q1 25 | — | 71.9% | ||
| Q4 24 | 40.7% | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | 40.9% | 67.7% | ||
| Q1 24 | 41.5% | 69.5% |
营业利润率MSMPODD
| Q4 25 | 7.9% | 18.7% | ||
| Q3 25 | 8.6% | 16.7% | ||
| Q2 25 | 8.5% | 18.7% | ||
| Q1 25 | — | 15.6% | ||
| Q4 24 | 7.8% | 18.3% | ||
| Q3 24 | — | 16.2% | ||
| Q2 24 | 10.9% | 11.2% | ||
| Q1 24 | 9.7% | 12.9% |
净利率MSMPODD
| Q4 25 | 5.4% | 13.0% | ||
| Q3 25 | 5.8% | 12.4% | ||
| Q2 25 | 5.9% | 3.5% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | 5.0% | 16.9% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | 7.3% | 38.6% | ||
| Q1 24 | 6.6% | 11.7% |
每股收益（稀释后）MSMPODD
| Q4 25 | $0.93 | $1.42 | ||
| Q3 25 | $1.02 | $1.24 | ||
| Q2 25 | $1.02 | $0.32 | ||
| Q1 25 | — | $0.50 | ||
| Q4 24 | $0.83 | $1.38 | ||
| Q3 24 | — | $1.08 | ||
| Q2 24 | $1.27 | $2.59 | ||
| Q1 24 | $1.10 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.3M | — |
| 总债务越低越好 | $214.1M | $930.8M |
| 股东权益账面价值 | $1.4B | $1.5B |
| 总资产 | $2.5B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.61× |
8季度趋势，按日历期对齐
现金及短期投资MSMPODD
| Q4 25 | $40.3M | — | ||
| Q3 25 | $56.2M | — | ||
| Q2 25 | $71.7M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $57.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $25.9M | — | ||
| Q1 24 | $22.2M | — |
总债务MSMPODD
| Q4 25 | $214.1M | $930.8M | ||
| Q3 25 | $168.8M | $934.9M | ||
| Q2 25 | $285.0M | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $289.9M | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $299.8M | $1.4B | ||
| Q1 24 | $294.5M | $1.4B |
股东权益MSMPODD
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $1.4B | $998.4M | ||
| Q1 24 | $1.4B | $790.7M |
总资产MSMPODD
| Q4 25 | $2.5B | $3.2B | ||
| Q3 25 | $2.5B | $3.0B | ||
| Q2 25 | $2.5B | $3.5B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | $2.5B | $3.1B | ||
| Q3 24 | — | $3.0B | ||
| Q2 24 | $2.5B | $2.9B | ||
| Q1 24 | $2.5B | $2.6B |
负债/权益比MSMPODD
| Q4 25 | 0.16× | 0.61× | ||
| Q3 25 | 0.12× | 0.68× | ||
| Q2 25 | 0.21× | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 0.21× | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | 0.21× | 1.36× | ||
| Q1 24 | 0.21× | 1.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.4M | $183.3M |
| 自由现金流经营现金流 - 资本支出 | $7.4M | $48.2M |
| 自由现金流率自由现金流/营收 | 0.8% | 6.2% |
| 资本支出强度资本支出/营收 | 2.3% | 17.2% |
| 现金转化率经营现金流/净利润 | 0.57× | 1.80× |
| 过去12个月自由现金流最近4个季度 | — | $377.7M |
8季度趋势，按日历期对齐
经营现金流MSMPODD
| Q4 25 | $29.4M | $183.3M | ||
| Q3 25 | — | $125.7M | ||
| Q2 25 | $151.6M | $196.5M | ||
| Q1 25 | — | $63.8M | ||
| Q4 24 | $101.9M | $147.7M | ||
| Q3 24 | — | $98.5M | ||
| Q2 24 | $143.5M | $96.5M | ||
| Q1 24 | $78.7M | $87.6M |
自由现金流MSMPODD
| Q4 25 | $7.4M | $48.2M | ||
| Q3 25 | — | $100.1M | ||
| Q2 25 | $100.7M | $177.9M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | $81.7M | $94.1M | ||
| Q3 24 | — | $71.8M | ||
| Q2 24 | $114.0M | $74.0M | ||
| Q1 24 | $53.4M | $65.5M |
自由现金流率MSMPODD
| Q4 25 | 0.8% | 6.2% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | 10.4% | 27.4% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | 8.8% | 15.7% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | 11.6% | 15.1% | ||
| Q1 24 | 5.7% | 14.8% |
资本支出强度MSMPODD
| Q4 25 | 2.3% | 17.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | 5.2% | 2.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 2.2% | 9.0% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | 3.0% | 4.6% | ||
| Q1 24 | 2.7% | 5.0% |
现金转化率MSMPODD
| Q4 25 | 0.57× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | 2.67× | 8.73× | ||
| Q1 25 | — | 1.80× | ||
| Q4 24 | 2.18× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | 2.00× | 0.51× | ||
| Q1 24 | 1.27× | 1.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MSM
暂无分部数据
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
